Terms: = Prostate cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
17 results:
1. The utility of the [-2]pro-prostate-specific antigen level as a prognostic marker in patients with castration-resistant prostate cancer treated with enzalutamide.
Miyazawa Y; Hori K; Tsuji Y; Sekine Y; Arai S; Fujizuka Y; Nomura M; Koike H; Matsui H; Suzuki K
Int J Urol; 2023 Oct; 30(10):839-846. PubMed ID: 37256915
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
3. Circulating microvesicles correlate with radiation proctitis complication after radiotherapy.
Ribault A; Benadjaoud MA; Squiban C; Arnaud L; Judicone C; Leroyer AS; Rousseau A; Huet C; Guha C; Benderitter M; Lacroix R; Flamant S; Chen EI; Simon JM; Tamarat R
Sci Rep; 2023 Feb; 13(1):2033. PubMed ID: 36739457
[TBL] [Abstract] [Full Text] [Related]
4. Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.
Haffner MC; Salles DC; Gao G; Epstein JI
Hum Pathol; 2020 Apr; 98():74-80. PubMed ID: 32119879
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Liu C; Zhu Y; Su H; Xu X; Zhang Y; Ye D; Hu S
Prostate; 2018 Dec; 78(16):1215-1221. PubMed ID: 30027591
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.
De Bruycker A; Lambert B; Claeys T; Delrue L; Mbah C; De Meerleer G; Villeirs G; De Vos F; De Man K; Decaestecker K; Fonteyne V; Lumen N; Ameye F; Billiet I; Joniau S; Vanhaverbeke F; Duthoy W; Ost P
BJU Int; 2017 Dec; 120(6):815-821. PubMed ID: 28646594
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant prostate cancer.
Vogelzang NJ; Fizazi K; Burke JM; De Wit R; Bellmunt J; Hutson TE; Crane E; Berry WR; Doner K; Hainsworth JD; Wiechno PJ; Liu K; Waldman MF; Gandhi A; Barton D; Jungnelius U; Fandi A; Sternberg CN; Petrylak DP
Eur Urol; 2017 Feb; 71(2):168-171. PubMed ID: 27522164
[TBL] [Abstract] [Full Text] [Related]
8. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract] [Full Text] [Related]
9. [Subclassification of the D'Amico's high risk group to predict biochemical recurrence after radical prostatectomy].
Kita Y; Inoue T; Shimizu Y; Kamba T; Yoshimura K; Ogawa O
Hinyokika Kiyo; 2012 Jul; 58(7):319-24. PubMed ID: 22895126
[TBL] [Abstract] [Full Text] [Related]
10. Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.
Stock RG; Berkowitz J; Blacksburg SR; Stone NN
BJU Int; 2012 Nov; 110(9):1257-61. PubMed ID: 22571680
[TBL] [Abstract] [Full Text] [Related]
11. miRNA-708 control of CD44(+) prostate cancer-initiating cells.
Saini S; Majid S; Shahryari V; Arora S; Yamamura S; Chang I; Zaman MS; Deng G; Tanaka Y; Dahiya R
Cancer Res; 2012 Jul; 72(14):3618-30. PubMed ID: 22552290
[TBL] [Abstract] [Full Text] [Related]
12. [Prognostic role of perineural invasion in prostate biopsy].
Gutiérrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
[TBL] [Abstract] [Full Text] [Related]
13. Serum level of IGFBP3 and IGF1/IGFBP3 molar ratio in addition to PSA and single nucleotide polymorphism in PSA and CYP17 gene may contribute to early diagnostics of prostate cancer.
Tajtakova M; Pidanicova A; Valansky L; Lachvac L; Nagy V; Sivonova M; Dobrota D; Kliment J; Petrovicova J
Neoplasma; 2010; 57(2):118-22. PubMed ID: 20099974
[TBL] [Abstract] [Full Text] [Related]
14. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
[TBL] [Abstract] [Full Text] [Related]
15. Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa).
Giton F; de la Taille A; Allory Y; Galons H; Vacherot F; Soyeux P; Abbou CC; Loric S; Cussenot O; Raynaud JP; Fiet J
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):158-67. PubMed ID: 18337090
[TBL] [Abstract] [Full Text] [Related]
16. [The meaning of PSA progression after radical prostatectomy. Preliminary results].
Luján Galán M; Pascual Mateo C; Rodríguez García N; Chiva Robles V; Escalera Almendros C; Angulo Cuesta J; Berenguer Sánchez A
Actas Urol Esp; 2006 Apr; 30(4):353-8. PubMed ID: 16838606
[TBL] [Abstract] [Full Text] [Related]
17. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma.
Keshgegian AA; Johnston E; Cnaan A
Am J Clin Pathol; 1998 Oct; 110(4):443-9. PubMed ID: 9763029
[TBL] [Abstract] [Full Text] [Related]
